In pulmonary embolism , fibrinolytic therapy is responsible for
Massive emboli
Risk of hemorrhage
All the above
None of the above
Hemorrhage is the main complication of fibrinolytic therapy, so it is contraindicated in all situations where the risk of bleeding is increased - recent trauma, surgery, biopsies, stroke, peptic ulcer, aneurysms, bleeding disorders, diabetes, acute pancreatitis etc.)
Cardio thoracic surgery  